MD&DI

09/10/2025

Boston Scientific is set to acquire Elutia's innovative BioEnvelope technology for $88 million, strengthening its position in the implantable medical device protection space.

The deal includes the FDA-approved EluPro antibiotic-eluting bioenvelope platform, which has already secured seven national group purchasing organization contracts and over 160 value analysis committee approvals since its June 2024 approval.

This strategic acquisition positions Boston Scientific to directly compete with Medtronic's established Tyrx pouch. https://bit.ly/3JTvcAK

The Marlborough, MA-based company has agreed to acquire Elutia’s BioEnvelope business for $88 million.

09/08/2025

AngioDynamics CEO James Clemmer discusses the effectiveness of the company's NanoKnife technology in this clip from the Let's Talk Medtech podcast. The device treats prostate cancer by using electrical pulses to destroy cancer cells while preserving healthy tissue. Listen to the full episode here:
https://bit.ly/46dxLFd

09/04/2025

North Carolina has emerged as the top destination for medical manufacturers onshoring operations, offering low taxes, abundant land, and specialized workforce training programs that attracted $10.8 billion in life sciences investment in 2024 alone. Check out the full analysis below.

North Carolina has emerged as the top destination for medical manufacturers onshoring operations, offering low taxes, abundant land, and specialized workforce training programs that attracted $10.8 billion in life sciences investment in 2024 alone.

09/04/2025

🔴 BREAKING NEWS: Senseonics Takes Control of Eversense 365 Commercialization

Senseonics, Incorporated has announced plans to bring the commercialization and distribution of its groundbreaking Eversense 365 continuous glucose monitoring system back in-house from Ascensia Diabetes Care, which has held exclusive worldwide distribution rights since 2020. https://bit.ly/469BOCp

Ascensia has held the exclusive worldwide distribution rights for the Eversense products since 2020.

09/03/2025

The latest episode of Let's Talk Medtech features James Clemmer, CEO of AngioDynamics, who discusses the company's transformative year across multiple therapeutic areas. He also discusses how a pivot in the product line helped change the course of the company.

This conversation offers valuable insights into how AngioDynamics is advancing patient care in both oncology and vascular treatments. Don't miss this episode if you're interested in the latest innovations reshaping medical device technology!

https://www.youtube.com/watch?v=B1eptnjclMI

AngioDynamics CEO Jim Clemmer reveals a strategic product portfolio transformation that revitalized the medical device company in this all new episode of Let...

09/02/2025

Trivia Tuesday: What medical device company did Carson Daly put on the map before it was bought by Boston Scientific?

Carson Daly suffered a T12 compression fracture in a 1997 snowmobile accident in Aspen. Years later, he underwent the Intracept procedure—a minimally invasive treatment for chronic vertebrogenic low back pain.

About a year after Daly's procedure, Boston Scientific bought _____________ for $850 million in cash, plus undisclosed payments contingent on sales performance over the following three years.

Find the answer at the link below.

What medical device company did Carson Daly put on the map before it was bought by Boston Scientific?

08/30/2025

Discover your true market value with our comprehensive 2025 MedTech Salary Survey Report!

Answer the questions that matter:
✓ Is your compensation truly competitive?
✓ Do you have grounds to negotiate a raise?
✓ How do your benefits stack up against industry standards?

Don't leave money on the table! Click now for FREE access to the full report and take control of your career trajectory today. https://www.utm.io/ui5AH

08/29/2025

Medtech freelancer Susan Shepard writes about the HeartBeam Inc. (NASDAQ: BEAT) portable ECG device. The credit-card-sized technology is transforming cardiac monitoring by collecting heart signals in three dimensions to synthesize a complete 12-lead ECG—offering significantly more diagnostic capability than single-lead consumer devices while maintaining incredible portability. https://bit.ly/4n5tV7M

HeartBeam's portable device collects signals in three dimensions for arrhythmia detection that is similar to hospital-type ECGs.

08/29/2025

This video highlights 3 of the 8 medical device companies most vulnerable to rising EU tariffs in 2025. Watch now to discover which manufacturers are navigating these challenges and how tariffs are impacting global healthcare supply chains.

Check out the link for the complete list of all 8 companies and our full analysis on how these trade policies could affect patient care worldwide. https://bit.ly/4oUEAnP

08/28/2025

Exciting preview from our upcoming Let's Talk Medtech episode featuring AngioDynamics CEO James Clemmer!

In this candid conversation, Clemmer shares how his remarkable career in sales helped him make the transition to a medtech CEO.

Stay tuned for the full episode dropping soon! What career questions would you like us to ask medtech executives in future episodes?

08/28/2025

Rachel Robinson, COO of MassMEDIC, tackles one of the medtech industry's biggest questions: How do we embrace AI innovation while navigating the complex maze of regulations and reimbursement?

Don't miss her thought-provoking Fireside Chat with leading female executives at MEDevice Boston, where they'll unpack the delicate balance between cutting-edge technology adoption and regulatory compliance.

Join the discussion and gain insights from those shaping the future of medtech!

MassMEDIC COO Rachel Robinson discusses the challenges of integrating new technologies like AI in medtech while balancing regulatory approvals and reimbursement concerns, ahead of her upcoming Fireside Chat with female executives at Boston MEDevice.

08/26/2025

In her New Heights podcast appearance, Taylor Swift opened up about her father's quintuple bypass surgery, discovered through a routine stress test.

Read how MD+DI Senior Editor Amanda Pedersen connects Swift's personal experience to the bigger picture in medtech innovation in this week's Pedersen's POV: https://www.utm.io/ui4Hp